{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T10:16:07Z","timestamp":1780568167617,"version":"3.54.1"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2020,8,6]],"date-time":"2020-08-06T00:00:00Z","timestamp":1596672000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,8,6]],"date-time":"2020-08-06T00:00:00Z","timestamp":1596672000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Instituto de Salud Carlos III (ES).FEDER","award":["PI18\/00316"],"award-info":[{"award-number":["PI18\/00316"]}]},{"DOI":"10.13039\/100007801","name":"Fundaci\u00f3n S\u00e9neca","doi-asserted-by":"publisher","award":["20644\/JLI\/18"],"award-info":[{"award-number":["20644\/JLI\/18"]}],"id":[{"id":"10.13039\/100007801","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Assist Reprod Genet"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1007\/s10815-020-01907-2","type":"journal-article","created":{"date-parts":[[2020,8,6]],"date-time":"2020-08-06T20:02:54Z","timestamp":1596744174000},"page":"2473-2476","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Successful ovarian stimulation and pregnancy in an infertile woman with chronic myeloid leukemia"],"prefix":"10.1007","volume":"37","author":[{"given":"Silvina J.","family":"Rios","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorena","family":"Mart\u00ednez-Montesinos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Aroca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raul","family":"Teruel-Montoya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9520-3243","authenticated-orcid":false,"given":"Francisca","family":"Ferrer-Mar\u00edn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,8,6]]},"reference":[{"issue":"6","key":"1907_CR1","doi-asserted-by":"publisher","first-page":"1336","DOI":"10.1038\/leu.2015.73","volume":"29","author":"VS Hoffmann","year":"2015","unstructured":"Hoffmann VS, Baccarani M, Hasford J, Lindoerfer D, Burgstaller S, Sertic D, et al. The EUTOS population-based registry: incidence and clinical characteristics of 2904 CML patients in 20 European Countries. Leukemia. 2015;29(6):1336\u201343. https:\/\/doi.org\/10.1038\/leu.2015.73.","journal-title":"Leukemia."},{"key":"1907_CR2","unstructured":"NCCN Guidelines Insights: Chronic Myeloid Leukemia V, Jan.30,2020."},{"issue":"4","key":"1907_CR3","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1038\/s41375-020-0776-2","volume":"34","author":"A Hochhaus","year":"2020","unstructured":"Hochhaus A, Baccarani M, Silver RT, Schiffer C, Apperley JF, Cervantes F, et al. European LeukemiaNet 2020 recommendations for treating chronic myeloid leukemia. Leukemia. 2020;34(4):966\u201384. https:\/\/doi.org\/10.1038\/s41375-020-0776-2.","journal-title":"Leukemia."},{"key":"1907_CR4","unstructured":"Novartis Pharmaceuticals Corporation. Gleevec Full Prescribibg Information. Update, July 2018. East Hanover, New Jersey 2018."},{"issue":"12","key":"1907_CR5","doi-asserted-by":"publisher","first-page":"5505","DOI":"10.1182\/blood-2007-10-114900","volume":"111","author":"SM Pye","year":"2008","unstructured":"Pye SM, Cortes J, Ault P, Hatfield A, Kantarjian H, Pilot R, et al. The effects of imatinib on pregnancy outcome. Blood. 2008;111(12):5505\u20138. https:\/\/doi.org\/10.1182\/blood-2007-10-114900.","journal-title":"Blood."},{"issue":"Sup 1","key":"1907_CR6","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1182\/blood-2018-99-118908","volume":"132","author":"EEC Abruzzese","year":"2018","unstructured":"Abruzzese EEC, Castagnetti F, et al. Gimema registry of conception\/pregnancy in adult Italian patients diagnosed with chronic myeloid leukemia (CML): report on 166 outcomes. Blood. 2018;132(Sup 1):43. https:\/\/doi.org\/10.1182\/blood-2018-99-118908.","journal-title":"Blood"},{"issue":"35","key":"1907_CR7","doi-asserted-by":"publisher","first-page":"6041","DOI":"10.1200\/JCO.2009.25.0779","volume":"27","author":"M Baccarani","year":"2009","unstructured":"Baccarani M, Cortes J, Pane F, Niederwieser D, Saglio G, Apperley J, et al. Chronic myeloid leukemia: an update of concepts and management recommendations of European LeukemiaNet. J Clin Oncol. 2009;27(35):6041\u201351. https:\/\/doi.org\/10.1200\/JCO.2009.25.0779.","journal-title":"J Clin Oncol"},{"issue":"10","key":"1907_CR8","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.6004\/jnccn.2009.0069","volume":"7","author":"J Apperley","year":"2009","unstructured":"Apperley J. Issues of imatinib and pregnancy outcome. J Natl Compr Canc Netw. 2009;7(10):1050\u20138. https:\/\/doi.org\/10.6004\/jnccn.2009.0069.","journal-title":"J Natl Compr Canc Netw"},{"issue":"1","key":"1907_CR9","first-page":"11","volume":"3","author":"PPK Yaghmaei","year":"2009","unstructured":"Yaghmaei PPK, Jalalvand F. Effect of imatinib on the oogenesis and pituitary -ovary hormonal axis in female Wistar rat. Int J Fertil Steril. 2009;3(1):11\u20136.","journal-title":"Int J Fertil Steril"},{"issue":"10","key":"1907_CR10","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1056\/NEJMc0707841","volume":"358","author":"C Christopoulos","year":"2008","unstructured":"Christopoulos C, Dimakopoulou V, Rotas E. Primary ovarian insufficiency associated with imatinib therapy. N Engl J Med. 2008;358(10):1079\u201380. https:\/\/doi.org\/10.1056\/NEJMc0707841.","journal-title":"N Engl J Med"},{"issue":"20","key":"1907_CR11","doi-asserted-by":"publisher","first-page":"2134","DOI":"10.1056\/NEJM200411113512024","volume":"351","author":"T Seshadri","year":"2004","unstructured":"Seshadri T, Seymour JF, McArthur GA. Oligospermia in a patient receiving imatinib therapy for the hypereosinophilic syndrome. N Engl J Med. 2004;351(20):2134\u20135. https:\/\/doi.org\/10.1056\/NEJM200411113512024.","journal-title":"N Engl J Med"},{"issue":"6","key":"1907_CR12","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1182\/blood-2013-05-501569","volume":"122","author":"M Baccarani","year":"2013","unstructured":"Baccarani M, Deininger MW, Rosti G, Hochhaus A, Soverini S, Apperley JF, et al. European LeukemiaNet recommendations for the management of chronic myeloid leukemia: 2013. Blood. 2013;122(6):872\u201384. https:\/\/doi.org\/10.1182\/blood-2013-05-501569.","journal-title":"Blood."},{"issue":"2","key":"1907_CR13","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1093\/molehr\/gal010","volume":"12","author":"KJ Hutt","year":"2006","unstructured":"Hutt KJ, McLaughlin EA, Holland MK. Kit ligand and c-Kit have diverse roles during mammalian oogenesis and folliculogenesis. Mol Hum Reprod. 2006;12(2):61\u20139. https:\/\/doi.org\/10.1093\/molehr\/gal010.","journal-title":"Mol Hum Reprod"},{"issue":"10","key":"1907_CR14","doi-asserted-by":"publisher","first-page":"1422","DOI":"10.1634\/theoncologist.2011-0137","volume":"16","author":"AM Zamah","year":"2011","unstructured":"Zamah AM, Mauro MJ, Druker BJ, Oktay K, Egorin MJ, Cedars MI, et al. Will imatinib compromise reproductive capacity? Oncologist. 2011;16(10):1422\u20137. https:\/\/doi.org\/10.1634\/theoncologist.2011-0137.","journal-title":"Oncologist"},{"issue":"6","key":"1907_CR15","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1634\/theoncologist.2017-0381","volume":"23","author":"S Gazdaru","year":"2018","unstructured":"Gazdaru S, Perey L, Rosselet A, Mathevet P, Chalandon Y, Vulliemoz N. Successful ovarian stimulation for fertility preservation in a patient with chronic myeloid leukemia: switch from nilotinib to interferon-alpha. Oncologist. 2018;23(6):719\u201321. https:\/\/doi.org\/10.1634\/theoncologist.2017-0381.","journal-title":"Oncologist"},{"issue":"1","key":"1907_CR16","doi-asserted-by":"publisher","DOI":"10.4084\/MJHID.2020.005","volume":"12","author":"Y Furukawa","year":"2020","unstructured":"Furukawa Y, Takahashi T, Suganuma R, Ohara M, Ota K, Kyozuka H, et al. Successful planned pregnancy through vitrified-warmed embryo transfer in a woman with chronic myeloid leukemia: case report and literature review. Mediterr J Hematol Infect Dis. 2020;12(1):e2020005. https:\/\/doi.org\/10.4084\/MJHID.2020.005.","journal-title":"Mediterr J Hematol Infect Dis"}],"container-title":["Journal of Assisted Reproduction and Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10815-020-01907-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10815-020-01907-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10815-020-01907-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,6]],"date-time":"2021-08-06T00:01:20Z","timestamp":1628208080000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10815-020-01907-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,6]]},"references-count":16,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2020,10]]}},"alternative-id":["1907"],"URL":"https:\/\/doi.org\/10.1007\/s10815-020-01907-2","relation":{},"ISSN":["1058-0468","1573-7330"],"issn-type":[{"value":"1058-0468","type":"print"},{"value":"1573-7330","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,6]]},"assertion":[{"value":"21 May 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 July 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 August 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}